FAME - Fampyra outcome measures study: a study of responsiveness of different outcome measures to Fampyra treatment.

Trial Profile

FAME - Fampyra outcome measures study: a study of responsiveness of different outcome measures to Fampyra treatment.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Oct 2015

At a glance

  • Drugs Fampridine (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms FAME
  • Most Recent Events

    • 02 Nov 2012 Planned End Date changed from 15 Feb 2015 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 02 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 04 Aug 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT01656148).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top